Tempus, the Future of Medicine Data System According to Eric Lefkofsky.
Meet Eric Lefkofsky, an American-based billionaire. He is a well-respected entrepreneur among his peers and has many titles to his name. Mr. Lefkofsky is a philanthropist, professor entrepreneur, author, and founder of Tempus. Tempus is a medical data tech-company based in Illinois Chicago. It has the most extensive electronic database of medical information on both molecular and clinical data. This helps clinicians to come up with the most appropriate medication that is personalized to meet a patient’s needs.
Tempus has grown tremendously over the recent years, with a recent audit conducted in 2018 estimated its worth to five US billion dollars in less than five years. It has employed over one thousand employees. Tempus collects and analyzes patient data at a molecular level, and it compares the data collected to the clinical information, pathological images, results found in the laboratory, and scans. All this is done to ensure that patient care is optimized by giving the patient the most suitable treatment or course of action. Initially, the company used the data in the treatment of diabetes and the management of depression, but its planning to expand its database to include oncology and cancer therapies.
Eric Lefkofsky served in various boards such as Lurie Children Hospital located in Chicago. He is a professor at the University of Chicago. He is a law graduate from the University of Michigan Law school. Also, he has written a book called ‘Understanding the Tue Speed of Innovation.’
Mr. Lefkofsky is an inspiration to many, and his example should be emulated.